Annual EBIT
-$670.76 M
-$213.06 M-46.55%
December 31, 2023
Summary
- As of February 7, 2025, INSM annual earnings before interest & taxes is -$670.76 million, with the most recent change of -$213.06 million (-46.55%) on December 31, 2023.
- During the last 3 years, INSM annual EBIT has fallen by -$406.24 million (-153.57%).
- INSM annual EBIT is now -660.80% below its all-time high of $119.61 million, reached on December 31, 2009.
Performance
INSM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$199.18 M
+$80.42 M+28.76%
September 30, 2024
Summary
- As of February 7, 2025, INSM quarterly earnings before interest & taxes is -$199.18 million, with the most recent change of +$80.42 million (+28.76%) on September 30, 2024.
- Over the past year, INSM quarterly EBIT has dropped by -$59.90 million (-43.01%).
- INSM quarterly EBIT is now -264.84% below its all-time high of $120.83 million, reached on March 31, 2009.
Performance
INSM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$780.57 M
-$59.90 M-8.31%
September 30, 2024
Summary
- As of February 7, 2025, INSM TTM earnings before interest & taxes is -$780.57 million, with the most recent change of -$59.90 million (-8.31%) on September 30, 2024.
- Over the past year, INSM TTM EBIT has dropped by -$129.98 million (-19.98%).
- INSM TTM EBIT is now -752.61% below its all-time high of $119.61 million, reached on December 31, 2009.
Performance
INSM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
INSM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.5% | -43.0% | -20.0% |
| 3 y3 years | -153.6% | -43.0% | -20.0% |
| 5 y5 years | -123.6% | -43.0% | -20.0% |
INSM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.6% | at low | -117.0% | +28.8% | -99.1% | at low |
| 5 y | 5-year | -195.2% | at low | -336.2% | +28.8% | -266.0% | at low |
| alltime | all time | -660.8% | at low | -264.8% | +28.8% | -752.6% | at low |
Insmed Incorporated EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$199.18 M(-28.8%) | -$780.57 M(+8.3%) |
| Jun 2024 | - | -$279.59 M(+104.7%) | -$720.67 M(+8.1%) |
| Mar 2024 | - | -$136.56 M(-17.4%) | -$666.38 M(-0.7%) |
| Dec 2023 | -$670.76 M(+46.6%) | -$165.24 M(+18.6%) | -$670.76 M(+3.1%) |
| Sep 2023 | - | -$139.28 M(-38.2%) | -$650.59 M(+1.7%) |
| Jun 2023 | - | -$225.31 M(+59.9%) | -$639.56 M(+26.2%) |
| Mar 2023 | - | -$140.93 M(-2.9%) | -$506.86 M(+10.7%) |
| Dec 2022 | -$457.70 M(+15.0%) | -$145.08 M(+13.1%) | -$457.70 M(+10.0%) |
| Sep 2022 | - | -$128.24 M(+38.5%) | -$416.18 M(+6.2%) |
| Jun 2022 | - | -$92.61 M(+0.9%) | -$391.98 M(-3.5%) |
| Mar 2022 | - | -$91.77 M(-11.4%) | -$406.21 M(+1.9%) |
| Dec 2021 | -$397.83 M(+50.4%) | -$103.56 M(-0.5%) | -$398.64 M(+2.3%) |
| Sep 2021 | - | -$104.05 M(-2.6%) | -$389.52 M(+13.9%) |
| Jun 2021 | - | -$106.84 M(+26.9%) | -$341.98 M(+18.1%) |
| Mar 2021 | - | -$84.19 M(-10.9%) | -$289.45 M(+9.4%) |
| Dec 2020 | -$264.52 M(+16.4%) | -$94.44 M(+67.1%) | -$264.52 M(+22.6%) |
| Sep 2020 | - | -$56.51 M(+4.1%) | -$215.75 M(+1.2%) |
| Jun 2020 | - | -$54.31 M(-8.4%) | -$213.28 M(-2.6%) |
| Mar 2020 | - | -$59.27 M(+29.8%) | -$218.96 M(-3.7%) |
| Dec 2019 | -$227.25 M(-24.3%) | -$45.67 M(-15.5%) | -$227.25 M(-14.8%) |
| Sep 2019 | - | -$54.04 M(-9.9%) | -$266.77 M(-9.3%) |
| Jun 2019 | - | -$59.99 M(-11.2%) | -$294.18 M(-3.4%) |
| Mar 2019 | - | -$67.56 M(-20.7%) | -$304.38 M(+1.5%) |
| Dec 2018 | -$300.00 M(+59.8%) | -$85.19 M(+4.6%) | -$300.00 M(+7.4%) |
| Sep 2018 | - | -$81.44 M(+16.0%) | -$279.28 M(+15.6%) |
| Jun 2018 | - | -$70.19 M(+11.1%) | -$241.69 M(+12.6%) |
| Mar 2018 | - | -$63.18 M(-2.0%) | -$214.64 M(+14.4%) |
| Dec 2017 | -$187.77 M(+8.7%) | -$64.46 M(+47.0%) | -$187.57 M(-1.3%) |
| Sep 2017 | - | -$43.85 M(+1.6%) | -$190.00 M(+3.8%) |
| Jun 2017 | - | -$43.15 M(+19.5%) | -$183.12 M(+4.1%) |
| Mar 2017 | - | -$36.11 M(-46.0%) | -$175.91 M(+1.9%) |
| Dec 2016 | -$172.68 M(+47.3%) | -$66.89 M(+81.0%) | -$172.68 M(+24.9%) |
| Sep 2016 | - | -$36.97 M(+2.9%) | -$138.28 M(+5.1%) |
| Jun 2016 | - | -$35.94 M(+9.3%) | -$131.55 M(+6.5%) |
| Mar 2016 | - | -$32.88 M(+1.2%) | -$123.50 M(+5.3%) |
| Dec 2015 | -$117.27 M(+34.5%) | -$32.49 M(+7.5%) | -$117.27 M(+8.7%) |
| Sep 2015 | - | -$30.24 M(+8.4%) | -$107.83 M(+6.8%) |
| Jun 2015 | - | -$27.89 M(+4.7%) | -$100.99 M(+5.5%) |
| Mar 2015 | - | -$26.65 M(+15.6%) | -$95.73 M(+9.8%) |
| Dec 2014 | -$87.17 M(+58.8%) | -$23.06 M(-1.4%) | -$87.17 M(+9.4%) |
| Sep 2014 | - | -$23.40 M(+3.4%) | -$79.71 M(+9.0%) |
| Jun 2014 | - | -$22.63 M(+25.2%) | -$73.12 M(+24.5%) |
| Mar 2014 | - | -$18.08 M(+15.9%) | -$58.71 M(+7.0%) |
| Dec 2013 | -$54.88 M(+35.1%) | -$15.60 M(-7.1%) | -$54.88 M(+1.3%) |
| Sep 2013 | - | -$16.80 M(+104.4%) | -$54.19 M(+16.4%) |
| Jun 2013 | - | -$8.22 M(-42.3%) | -$46.55 M(-3.1%) |
| Mar 2013 | - | -$14.26 M(-4.4%) | -$48.03 M(+18.3%) |
| Dec 2012 | -$40.61 M(-31.9%) | -$14.92 M(+62.8%) | -$40.61 M(+19.9%) |
| Sep 2012 | - | -$9.16 M(-5.5%) | -$33.86 M(-42.9%) |
| Jun 2012 | - | -$9.69 M(+41.7%) | -$59.29 M(-0.5%) |
| Mar 2012 | - | -$6.84 M(-16.2%) | -$59.61 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$59.65 M(+854.9%) | -$8.16 M(-76.4%) | -$59.65 M(+4.2%) |
| Sep 2011 | - | -$34.59 M(+245.4%) | -$57.26 M(+149.8%) |
| Jun 2011 | - | -$10.01 M(+45.4%) | -$22.92 M(+72.6%) |
| Mar 2011 | - | -$6.89 M(+19.5%) | -$13.28 M(+112.6%) |
| Dec 2010 | -$6.25 M(-105.2%) | -$5.76 M(+2178.7%) | -$6.25 M(+1313.3%) |
| Sep 2010 | - | -$253.00 K(-32.5%) | -$442.00 K(+63.1%) |
| Jun 2010 | - | -$375.00 K(-356.8%) | -$271.00 K(-74.8%) |
| Mar 2010 | - | $146.00 K(+265.0%) | -$1.08 M(-100.9%) |
| Dec 2009 | $119.61 M(-930.0%) | $40.00 K(-148.8%) | $119.61 M(+3.3%) |
| Sep 2009 | - | -$82.00 K(-93.1%) | $115.83 M(+1.6%) |
| Jun 2009 | - | -$1.18 M(-101.0%) | $114.03 M(+2.9%) |
| Mar 2009 | - | $120.83 M(-3332.5%) | $110.77 M(-845.6%) |
| Dec 2008 | -$14.41 M(-29.5%) | -$3.74 M(+98.2%) | -$14.86 M(+2.7%) |
| Sep 2008 | - | -$1.89 M(-57.5%) | -$14.46 M(-13.4%) |
| Jun 2008 | - | -$4.43 M(-7.6%) | -$16.70 M(+12.6%) |
| Mar 2008 | - | -$4.80 M(+43.5%) | -$14.83 M(-27.4%) |
| Dec 2007 | -$20.44 M(-62.4%) | -$3.34 M(-18.9%) | -$20.44 M(-46.9%) |
| Sep 2007 | - | -$4.12 M(+60.5%) | -$38.50 M(-18.3%) |
| Jun 2007 | - | -$2.57 M(-75.3%) | -$47.10 M(-12.5%) |
| Mar 2007 | - | -$10.40 M(-51.4%) | -$53.85 M(-1.0%) |
| Dec 2006 | -$54.37 M(+98.2%) | -$21.40 M(+68.2%) | -$54.37 M(+35.8%) |
| Sep 2006 | - | -$12.72 M(+36.5%) | -$40.03 M(+13.7%) |
| Jun 2006 | - | -$9.32 M(-14.6%) | -$35.20 M(+7.2%) |
| Mar 2006 | - | -$10.92 M(+54.6%) | -$32.83 M(+19.7%) |
| Dec 2005 | -$27.43 M(+0.0%) | -$7.06 M(-10.5%) | -$27.43 M(+4.5%) |
| Sep 2005 | - | -$7.90 M(+13.6%) | -$26.25 M(+1.0%) |
| Jun 2005 | - | -$6.95 M(+25.9%) | -$26.00 M(-7.5%) |
| Mar 2005 | - | -$5.52 M(-6.1%) | -$28.11 M(+2.5%) |
| Dec 2004 | -$27.43 M(+159.1%) | -$5.88 M(-23.1%) | -$27.43 M(+14.1%) |
| Sep 2004 | - | -$7.65 M(-15.6%) | -$24.05 M(+27.5%) |
| Jun 2004 | - | -$9.06 M(+87.4%) | -$18.87 M(+43.8%) |
| Mar 2004 | - | -$4.83 M(+93.1%) | -$13.12 M(+23.9%) |
| Dec 2003 | -$10.59 M(-69.3%) | -$2.50 M(+1.5%) | -$10.59 M(-60.4%) |
| Sep 2003 | - | -$2.47 M(-25.5%) | -$26.71 M(+0.7%) |
| Jun 2003 | - | -$3.31 M(+44.0%) | -$26.52 M(-13.0%) |
| Mar 2003 | - | -$2.30 M(-87.6%) | -$30.48 M(-11.6%) |
| Dec 2002 | -$34.49 M(-14.2%) | -$18.62 M(+717.2%) | -$34.49 M(+32.1%) |
| Sep 2002 | - | -$2.28 M(-68.7%) | -$26.11 M(-20.4%) |
| Jun 2002 | - | -$7.28 M(+15.4%) | -$32.80 M(-6.7%) |
| Mar 2002 | - | -$6.31 M(-38.4%) | -$35.15 M(-12.5%) |
| Dec 2001 | -$40.19 M(+29.2%) | -$10.24 M(+14.1%) | -$40.19 M(-448.9%) |
| Sep 2001 | - | -$8.97 M(-6.8%) | $11.52 M(-22.9%) |
| Jun 2001 | - | -$9.63 M(-15.1%) | $14.95 M(-148.2%) |
| Mar 2001 | - | -$11.35 M(-127.4%) | -$31.02 M(-0.2%) |
| Dec 2000 | -$31.10 M(+282.5%) | $41.47 M(-847.8%) | -$31.10 M(-57.1%) |
| Sep 2000 | - | -$5.54 M(-90.0%) | -$72.56 M(+8.3%) |
| Jun 2000 | - | -$55.60 M(+386.9%) | -$67.02 M(+411.8%) |
| Mar 2000 | - | -$11.42 M(+581.3%) | -$13.10 M(+302.2%) |
| Dec 1999 | -$8.13 M | - | - |
| Jun 1999 | - | -$1.68 M(+6.1%) | -$3.26 M(+106.1%) |
| Mar 1999 | - | -$1.58 M | -$1.58 M |
FAQ
- What is Insmed Incorporated annual earnings before interest & taxes?
- What is the all time high annual EBIT for Insmed Incorporated?
- What is Insmed Incorporated annual EBIT year-on-year change?
- What is Insmed Incorporated quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Insmed Incorporated?
- What is Insmed Incorporated quarterly EBIT year-on-year change?
- What is Insmed Incorporated TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Insmed Incorporated?
- What is Insmed Incorporated TTM EBIT year-on-year change?
What is Insmed Incorporated annual earnings before interest & taxes?
The current annual EBIT of INSM is -$670.76 M
What is the all time high annual EBIT for Insmed Incorporated?
Insmed Incorporated all-time high annual earnings before interest & taxes is $119.61 M
What is Insmed Incorporated annual EBIT year-on-year change?
Over the past year, INSM annual earnings before interest & taxes has changed by -$213.06 M (-46.55%)
What is Insmed Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of INSM is -$199.18 M
What is the all time high quarterly EBIT for Insmed Incorporated?
Insmed Incorporated all-time high quarterly earnings before interest & taxes is $120.83 M
What is Insmed Incorporated quarterly EBIT year-on-year change?
Over the past year, INSM quarterly earnings before interest & taxes has changed by -$59.90 M (-43.01%)
What is Insmed Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of INSM is -$780.57 M
What is the all time high TTM EBIT for Insmed Incorporated?
Insmed Incorporated all-time high TTM earnings before interest & taxes is $119.61 M
What is Insmed Incorporated TTM EBIT year-on-year change?
Over the past year, INSM TTM earnings before interest & taxes has changed by -$129.98 M (-19.98%)